MedTrace Logo

Comparison of MedCem MTA and Formocresol Used in Pulpotomies in Primary Teeth.

NCT01962077 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-07-06

No results posted yet for this study

Summary

assess the effect of MedCem MTA as a pulp medicament following pulpotomy in human primary molars with carious pulp exposure in comparison to Formocresol.

Conditions

  • Pulpotomies Primary Teeth
  • Effectiveness of MedCem MTA® in Pulpotomies Primary Teeth

Interventions

PROCEDURE

MedCem MTA pulpotomies in primary teeth.

Sponsors & Collaborators

  • Hadassah Medical Organization

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01962077 on ClinicalTrials.gov